title: Extracorporeal shockwave lithotripsy in anomalous kidneys.
abstract: OBJECTIVE
  Extracorporeal shockwave lithotripsy (SWL) is accepted as first-line therapy for kidney stones. The aim of this study was to evaluate SWL therapy in patients with congenital urinary system anomalies.
  
  
  METHODS
  A total of 120 patients with congenital urinary system anomalies and kidney stones who underwent SWL treatment were evaluated. Of these patients, 44 (37%) had horseshoe kidneys, 22 (18%) had rotation anomalies, 13 (11%) had pelvic kidneys, and 41 (34%) had ureteral duplications. The mean stone size was 2.09+/-0.71 (range 0.8-4.6) cm2, and a total of 232 sessions (1.93 sessions/patient) were applied.
  
  
  RESULTS
  The overall stone-free rate after completion of the SWL treatments was 70% (84 patients). In horse shoe kidneys the stone-free rate was 68%, and sufficient fragmentation was achieved in another 21%. These values were 59% and 32%, respectively, for malrotated kidneys, 54% and 39% for pelvic kidneys, and 83% and 12% for ureteral duplications. The 10 patients in whom SWL treatment remained unsuccessful had horse-shoe kidneys (five cases), malrotated kidneys (two cases), pelvic kidney (one case), and ureteral duplication (two cases). Open surgery was performed in eight patients with renal anomalies, and ureteroendoscopic lithotripsy was performed in two patients with ureteral duplication.
  
  
  CONCLUSIONS
  Shockwave lithotripsy is an effective and reliable treatment method in patients with congenital urinary system anomalies, especially when the stones are <2 cm. Patients with ureteral duplication had the overall best stone-free rates. However, patients who have stones > or =3 cm in horseshoe or malrotated kidneys and duplex systems seem to be better candidates for percutaneous nephrolithotomy or open surgery.
authors.affiliation: Department of Urology, Gazi University School of Medicine, Ankara, Turkey. borakupeli@hotmail.com
authors.forename: B
authors.initials: B
authors.lastname: Küpeli
authors.forename: K
authors.initials: K
authors.lastname: Isen
authors.forename: H
authors.initials: H
authors.lastname: Biri
authors.forename: Z
authors.initials: Z
authors.lastname: Sinik
authors.forename: T
authors.initials: T
authors.lastname: Alkibay
authors.forename: U
authors.initials: U
authors.lastname: Karaoğlan
authors.forename: I
authors.initials: I
authors.lastname: Bozkirli
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007668:Kidney / Q000002:abnormalities*; D007669:Kidney Calculi / Q000209:etiology / Q000628:therapy*; D007674:Kidney Diseases / Q000151:congenital; D008096:Lithotripsy; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D014513:Ureter / Q000002:abnormalities; D014515:Ureteral Diseases / Q000151:congenital